Hypera SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hypera SA with three other
pharmaceutical manufacturers in Latin America:
Genomma Lab Internacional Sab De Cv
of MEXICO
(2019
sales of 12.76 billion Mexican Pesos [US$526.18 million]
),
Diagnosticos Da America SA
(4.36 billion Brazilian Reals [US$831.37 million]
of which 100%
was servi os auxiliares), and
Fleury SA
(2.91 billion Brazilian Reals [US$553.36 million]
of which 84%
was Diagnostic Medicine).
Sales Analysis.
Hypera SA reported sales of 3.29 billion Brazilian Reals (US$627.58 million)
for the
year ending
December of 2019.
This
represents
a
decrease of 11.5%
versus 2018, when the company's sales were 3.72 billion Brazilian Reals.